Learn About Cardiomyopathy

What is the definition of Cardiomyopathy?

Cardiomyopathy is disease in which the heart muscle becomes weakened, stretched, or has another structural problem. It often contributes to the heart's inability to pump or function well.

Many people with cardiomyopathy have heart failure.

What are the causes of Cardiomyopathy?

There are many types of cardiomyopathy, with different causes. Some of the more common ones are:

  • Dilated cardiomyopathy (also called idiopathic dilated cardiomyopathy if there is no known cause) is a condition in which the heart becomes weak and the chambers get large. As a result, the heart cannot pump enough blood out to the body. It can be caused by many medical problems.
  • Hypertrophic cardiomyopathy (HCM) is a condition in which the heart muscle becomes thick. This makes it harder for blood to leave the heart. This type of cardiomyopathy is most often passed down through families.
  • Ischemic cardiomyopathy is caused by a narrowing of the arteries that supply the heart with blood. It makes the heart walls thin so they do not pump well.
  • Restrictive cardiomyopathy is a group of disorders. The heart chambers are unable to fill with blood because the heart muscle is stiff. The most common causes of this type of cardiomyopathy are amyloidosis and scarring of the heart from an unknown cause.
  • Peripartum cardiomyopathy occurs during pregnancy or in the first 5 months afterward.
What are the current treatments for Cardiomyopathy?

When possible, the cause of cardiomyopathy is treated. Medicines and lifestyle changes are often needed to treat the symptoms of heart failure, angina and abnormal heart rhythms.

Procedures or surgeries may also be used, including:

  • A defibrillator that sends an electrical pulse to stop life-threatening abnormal heart rhythms
  • A pacemaker that treats a slow heart rate or helps the heart beat in a more coordinated fashion
  • Coronary artery bypass (CABG) surgery or angioplasty that may improve blood flow to the damaged or weakened heart muscle
  • Heart transplant that may be tried when all other treatments have failed

Partially and fully implantable mechanical heart pumps have been developed. These may be used for very severe cases. However, not all people need this advanced treatment.

Who are the top Cardiomyopathy Local Doctors?
16018 Tuscola Rd, Suite 9, 
Apple Valley, CA 
 8.4 mi

Mukeshchandra Patel is a Cardiologist in Apple Valley, California. Dr. Patel and is rated as an Advanced provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Unstable Angina, Necrosis, Apoplexy, Pacemaker Implantation, and Bone Marrow Aspiration.

Cardiology | Nuclear Medicine | Radiology
Cardiology | Nuclear Medicine | Radiology
12780 Hesperia Rd, 
Victorville, CA 
 9.6 mi
Offers Telehealth

Siva Arunasalam is a Cardiologist and a Nuclear Medicine provider in Victorville, California. Dr. Arunasalam and is rated as an Advanced provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Angina, Heart Attack, Vitamin B12 Deficiency, Pacemaker Implantation, and Colonoscopy.

 
 
 
 
Learn about our expert tiers
Learn More
Cardiology | Interventional Cardiology
Cardiology | Interventional Cardiology

Syed J Raza MD Inc

15962 Quantico Rd, 
Apple Valley, CA 
 8.4 mi
Offers Telehealth

Syed Raza is a Cardiologist and an Interventional Cardiologist in Apple Valley, California. Dr. Raza and is rated as an Experienced provider by MediFind in the treatment of Cardiomyopathy. His top areas of expertise are Familial Hypertension, Hypertension, Glucocorticoid-Remediable Aldosteronism, Atherosclerosis, and Pacemaker Implantation.

What is the outlook (prognosis) for Cardiomyopathy?

The outlook depends on many different things, including:

  • Cause and type of cardiomyopathy
  • The severity of the heart problem
  • How long the problem has been present
  • How well the condition responds to treatment

Heart failure is most often a long-term (chronic) illness. It may get worse over time. Some people develop severe heart failure. In this case, medicines, surgery, and other treatments may no longer help.

People with certain types of cardiomyopathy are at risk for dangerous heart rhythm problems.

What are the latest Cardiomyopathy Clinical Trials?
the Role of cArdiac Inflammation, endoThelial Dysfunction, and FIbrosis in fabrY Disease

Summary: The overall objective of this study is to investigate Fabry-related cardiomyopathy, evaluating native T1-mapping, coronary microvascular function, cardiac inflammation, and cardiac injury in an effort to improve the ability to detect disease and ease diagnostics. The study aims to achieve this by: 1. Investigating the association between cardiac inflammation, fibrosis, and injury against the distr...

Match to trials
Find the right clinical trials for you in under a minute
Get started
NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study

Background: Some people have a condition in which the wall (septum) that separates the two main pumping chambers of the heart is too thick. This thick septum causes a condition called left ventricular outflow tract obstruction (LVOTO), which reduces blood flow out of the heart. LVOTO can cause serious heart disease; symptoms may include shortness of breath, chest pain, heart failure, or death. Researchers wan...

Who are the sources who wrote this article ?

Published Date: May 08, 2022
Published By: Michael A. Chen, MD, PhD, Associate Professor of Medicine, Division of Cardiology, Harborview Medical Center, University of Washington Medical School, Seattle, WA. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Hershberger RE. The dilated, restrictive, and infiltrative cardiomyopathies. In: Libby P, Bonow RO, Mann DL, Tomaselli GF, Bhatt DL, Solomon SD, eds. Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. 12th ed. Philadelphia, PA: Elsevier; 2022:chap 52.

Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA/ACC/HFSA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. J Am Coll Cardiol. 2022;79(17):e263-e421. PMID: 35379503 pubmed.ncbi.nlm.nih.gov/35379503/.

McKenna WJ, Elliott PM. Diseases of the myocardium and endocardium. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 54.

McMurray JJV, Pfeffer MA. Heart failure: management and prognosis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 53.

Rogers JG, O'Connor CM. Heart failure: pathophysiology and diagnosis. In: Goldman L, Schafer AI, eds. Goldman-Cecil Medicine. 26th ed. Philadelphia, PA: Elsevier; 2020:chap 52.